{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:52:56Z","timestamp":1793116376410,"version":"4.5.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T00:00:00Z","timestamp":1719187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.amjmed.2024.04.030","type":"journal-article","created":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T02:57:14Z","timestamp":1715309834000},"page":"884-892.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["The PAX LC Trial: A Decentralized, Phase 2, Randomized, Double-Blind Study of Nirmatrelvir\/Ritonavir Compared with Placebo\/Ritonavir for Long COVID"],"prefix":"10.1016","volume":"138","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2046-127X","authenticated-orcid":false,"given":"Harlan M.","family":"Krumholz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuaki","family":"Sawano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bornali","family":"Bhattacharjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar","family":"Caraballo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"Khera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeph","family":"Herrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Coppi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Holub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yashira","family":"Henriquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa B.","family":"Goddard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Rocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy C.","family":"Hummel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"AL Mouslmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.","family":"Putrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin D.","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santos","family":"Carvajal-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Charnas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdia","family":"De Jesus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Frank W.","family":"Ziegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2024.04.030_bib0001","unstructured":"Centers for Disease Control and Prevention. Long COVID or post-COVID conditions. Available at: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/long-term-effects\/index.html. Accessed April 26, 2024."},{"issue":"21","key":"10.1016\/j.amjmed.2024.04.030_bib0002","first-page":"713","article-title":"Post\u2013COVID conditions among adult COVID-19 survivors aged 18\u201364 and \u226565 years\u2014United States, March 2020\u2013November 2021","volume":"71","author":"Bull-Otterson","year":"2022","journal-title":"MMWR"},{"key":"10.1016\/j.amjmed.2024.04.030_bib0003","unstructured":"Centers for Disease Control and Prevention; National Center for Health Statistics. Long COVID: household pulse survey. Available at: https:\/\/www.cdc.gov\/nchs\/covid19\/pulse\/long-covid.htm. Accessed April 26, 2024."},{"issue":"5","key":"10.1016\/j.amjmed.2024.04.030_bib0004","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s41591-022-01810-6","article-title":"Unexplained post-acute infection syndromes","volume":"28","author":"Choutka","year":"2022","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.amjmed.2024.04.030_bib0005","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","article-title":"Long COVID: major findings, mechanisms and recommendations","volume":"21","author":"Davis","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.amjmed.2024.04.030_bib0006","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1038\/s41590-023-01601-2","article-title":"SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)","volume":"24","author":"Proal","year":"2023","journal-title":"Nat Immunol"},{"key":"10.1016\/j.amjmed.2024.04.030_bib0007","unstructured":"Burns A. What are the implications of long COVID for employment and health coverage? 2022. Available at: https:\/\/wwwkfforg\/policy-watch\/what-are-the-implications-of-long-covid-for-employment-and-health-coverage\/. Accessed April 26, 2024."},{"key":"10.1016\/j.amjmed.2024.04.030_bib0008","article-title":"Plasma-based antigen persistence in the post-acute phase of SARS-CoV-2 infection","author":"Peluso","year":"2023","journal-title":"medRxiv"},{"issue":"3","key":"10.1016\/j.amjmed.2024.04.030_bib0009","doi-asserted-by":"crossref","first-page":"e487","DOI":"10.1093\/cid\/ciac722","article-title":"Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae","volume":"76","author":"Swank","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"22","key":"10.1016\/j.amjmed.2024.04.030_bib0010","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1016\/j.cell.2023.09.013","article-title":"Serotonin reduction in post-acute sequelae of viral infection","volume":"186","author":"Wong","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.amjmed.2024.04.030_bib0011","article-title":"Nirmatrelvir and the risk of post-acute sequelae of COVID-19","author":"Xie","year":"2022","journal-title":"medRxiv"},{"key":"10.1016\/j.amjmed.2024.04.030_bib0012","unstructured":"Hugo Health. Available at: https:\/\/hugo.health\/. Accessed April 26, 2024."},{"key":"10.1016\/j.amjmed.2024.04.030_bib0013","unstructured":"World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus; 6 October 2021. Available at: https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1. Accessed April 26, 2024."},{"key":"10.1016\/j.amjmed.2024.04.030_bib0014","unstructured":"Office of the Director; National Institutes of Health. Populations underrepresented in the extramural scientific workforce; 2019. Available at: https:\/\/diversity.nih.gov\/about-us\/population-underrepresented. Accessed April 26, 2024."},{"issue":"43","key":"10.1016\/j.amjmed.2024.04.030_bib0015","doi-asserted-by":"crossref","first-page":"18422","DOI":"10.1073\/pnas.1010693107","article-title":"Structure and mechanism of the complex between cytochrome P4503A4 and ritonavir","volume":"107","author":"Sevrioukova","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.amjmed.2024.04.030_bib0016","unstructured":"Health Measures. PROMIS. Available at: https:\/\/www.healthmeasures.net\/explore-measurement-systems\/promis. Accessed April 26, 2024."},{"issue":"7","key":"10.1016\/j.amjmed.2024.04.030_bib0017","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1007\/s11136-018-1842-3","article-title":"PROMIS(\u00ae)-29 v2.0 profile physical and mental health summary scores","volume":"27","author":"Hays","year":"2018","journal-title":"Qual Life Res"},{"key":"10.1016\/j.amjmed.2024.04.030_bib0018","unstructured":"US Food and Drug Administration. Fact sheet for healthcare providers: emergency use authorization for Paxlovid. Available at: https:\/\/www.fda.gov\/media\/155050\/download. Accessed April 26, 2024."},{"key":"10.1016\/j.amjmed.2024.04.030_bib0019","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41586-023-06651-y","article-title":"Distinguishing features of long COVID identified through immune profiling","volume":"623","author":"Klein","year":"2023","journal-title":"Nature"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934324002717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934324002717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:30:53Z","timestamp":1762079453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934324002717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0002934324002717"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2024.04.030","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The PAX LC Trial: A Decentralized, Phase 2, Randomized, Double-Blind Study of Nirmatrelvir\/Ritonavir Compared with Placebo\/Ritonavir for Long COVID","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2024.04.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}